Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.2K Hold
383
0.01% 454
2025
Q4
$67.4K Sell
383
-18
-4% -$2.94K 0.01% 439
2025
Q3
$56.2K Hold
401
0.01% 456
2025
Q2
$50.4K Sell
401
-253
-39% -$31.5K 0.01% 467
2025
Q1
$89.5K Sell
654
-8
-1% -$1.14K 0.01% 389
2024
Q4
$101K Sell
662
-6
-0.9% -$1.01K 0.01% 377
2024
Q3
$129K Sell
668
-25
-4% -$5.23K 0.01% 363
2024
Q2
$161K Hold
693
0.02% 330
2024
Q1
$149K Sell
693
-68
-9% -$15.9K 0.02% 340
2023
Q4
$197K Hold
761
0.02% 300
2023
Q3
$196K Hold
761
0.03% 292
2023
Q2
$217K Hold
761
0.03% 286
2023
Q1
$212K Hold
761
0.03% 278
2022
Q4
$211K Hold
761
0.03% 273
2022
Q3
$203K Sell
761
-65
-8% -$13.8K 0.03% 263
2022
Q2
$168K Sell
826
-27
-3% -$5.52K 0.02% 297
2022
Q1
$180K Sell
853
-170
-17% -$37K 0.02% 297
2021
Q4
$245K Sell
1,023
-35
-3% -$9K 0.03% 261
2021
Q3
$299K Sell
1,058
-65
-6% -$21.3K 0.04% 237
2021
Q2
$389K Buy
1,123
+56
+5% +$17K 0.05% 214
2021
Q1
$298K Sell
1,067
-241
-18% -$65K 0.04% 221
2020
Q4
$320K Sell
1,308
-23
-2% -$5.93K 0.05% 208
2020
Q3
$378K Sell
1,331
-304
-19% -$84.8K 0.06% 192
2020
Q2
$437K Sell
1,635
-51
-3% -$15.3K 0.07% 184
2020
Q1
$533K Sell
1,686
-217
-11% -$65.9K 0.1% 148
2019
Q4
$565K Buy
+1,903
New +$528K 0.09% 168

Other funds holding BIIB

Caldwell Trust's BIIB Position: Q1 2026 in Review

Caldwell Trust held its Biogen (BIIB) position steady in Q1 2026 at 383 shares worth $70.2K. The position accounts for 0.01% of the portfolio, ranked #454.

Caldwell Trust first reported a position in BIIB in Q4 2019 and has held it in 26 quarters since. The position peaked at $565K in Q4 2019. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Caldwell Trust held 383 shares of Biogen worth $70.2K as of Q1 2026.
  • Caldwell Trust left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.01% of Caldwell Trust's portfolio in Q1 2026, its #454 holding.
  • Caldwell Trust first reported a position in Biogen in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's Biogen position peaked at $565K in Q4 2019.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.